atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
exparel liposomal
pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.
zenalpha
vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psykoleptika, hypnotika och lugnande medel - hundar - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.
ropivacain fresenius kabi 10 mg/ml injektionsvätska, lösning
fresenius kabi ab - ropivakainhydroklorid, vattenfri - injektionsvätska, lösning - 10 mg/ml - ropivakainhydroklorid, vattenfri 10 mg aktiv substans - ropivakain
ropivacain fresenius kabi 2 mg/ml injektionsvätska, lösning
fresenius kabi ab - ropivakainhydroklorid, vattenfri - injektionsvätska, lösning - 2 mg/ml - ropivakainhydroklorid, vattenfri 2 mg aktiv substans - ropivakain
ropivacain fresenius kabi 7,5 mg/ml injektionsvätska, lösning
fresenius kabi ab - ropivakainhydroklorid, vattenfri - injektionsvätska, lösning - 7,5 mg/ml - ropivakainhydroklorid, vattenfri 7,5 mg aktiv substans - ropivakain
ropivakain sintetica 10 mg/ml injektionsvätska, lösning
sintetica gmbh - ropivakainhydrokloridmonohydrat - injektionsvätska, lösning - 10 mg/ml - ropivakainhydrokloridmonohydrat 10,58 mg aktiv substans - ropivakain
ropivakain sintetica 2 mg/ml injektionsvätska, lösning
sintetica gmbh - ropivakainhydrokloridmonohydrat - injektionsvätska, lösning - 2 mg/ml - ropivakainhydrokloridmonohydrat 2,12 mg aktiv substans - ropivakain
ropivakain sintetica 2 mg/ml infusionsvätska, lösning
sintetica gmbh - ropivakainhydrokloridmonohydrat - infusionsvätska, lösning - 2 mg/ml - ropivakainhydrokloridmonohydrat 2,12 mg aktiv substans - ropivakain
ropivakain sintetica 7,5 mg/ml injektionsvätska, lösning
sintetica gmbh - ropivakainhydrokloridmonohydrat - injektionsvätska, lösning - 7,5 mg/ml - ropivakainhydrokloridmonohydrat 7,93 mg aktiv substans - ropivakain